Weikang Pharmaceutical: Announcement on the postponement of some fund-raising investment projects
Weikang Pharmaceutical: Table of non-operating capital occupation and other related capital transactions of Weikang Pharmaceutical for the first half year of 2024
Zhejiang Wecome Pharmaceutical: Announcement of the resolution of the first extraordinary Shareholders' Meeting in 2024.
Zhejiang Wecome Pharmaceutical: Legal opinion for the first extraordinary shareholder meeting in 2024.
Zhejiang Wecome Pharmaceutical: Announcement Regarding Changes to the Company's Pharmaceutical Production License
Zhejiang Wecome Pharmaceutical: Notice of the First Extraordinary Shareholders' Meeting in 2024
Zhejiang Wecome Pharmaceutical: Tianjian Review [2024] No. 9850 - Zhejiang Vicom Medical Retail Co., Ltd. 430 Report
Zhejiang Wecome Pharmaceutical: Announcement on the reply to the inquiry letter of the 2023 annual report of the Shenzhen Stock Exchange.
Zhejiang Wecome Pharmaceutical: Notice regarding the receipt of the summary report of the phase IIb clinical trial of Silver Yellow Pill.
Zhejiang Wecome Pharmaceutical: Announcement regarding the further extension of the response to Shenzhen Stock Exchange's annual report inquiry letter.
Zhejiang Wecome Pharmaceutical: Announcement Regarding the Delay in Responding to Shenzhen Stock Exchange's Inquiry Letter on Annual Reports.
Zhejiang Wecome Pharmaceutical: Announcement regarding the completion of industrial and commercial change registration and issuance of business license.
Zhejiang Wecome Pharmaceutical: Notice on receiving a warning letter from the Zhejiang Securities Regulatory Bureau
Zhejiang Wecome Pharmaceutical: Announcement on the wholly-owned subsidiary planning to sell subsidiary shares and sign an agreement of intent
Zhejiang Wecome Pharmaceutical: Announcement on the completion of the general election of the Board of Directors and the Board of Supervisors and the appointment of senior management and representatives of securities affairs
Zhejiang Wecome Pharmaceutical: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders
Zhejiang Wecome Pharmaceutical: 2023 Annual General Meeting of Shareholders Legal Opinions
Zhejiang Wecome Pharmaceutical: 2023 Internal Control Self-Assessment Report
Zhejiang Wecome Pharmaceutical: Notice on convening the 2023 Annual General Meeting of Shareholders (after correction)
Zhejiang Wecome Pharmaceutical: Corrective Notice Concerning the Notice of Convening the 2023 Annual General Meeting of Shareholders
No Data
No Data